Financhill
Back

Y-mAbs Therapeutics Vs. Humacyte Industry Stock Comparison

Sell
35

YMAB
Y-mAbs Therapeutics

Last Price:
12.29
Seasonality Move:
18.11%
Buy
82

HUMA
Humacyte

Last Price:
4.69
Seasonality Move:
-25.74%
Sell
35
Y-mAbs Therapeutics (YMAB) is a Sell

Is Y-mAbs Therapeutics a Buy, Sell or Hold?

  • The current Y-mAbs Therapeutics [YMAB] share price is $12.87. The Score for YMAB is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • YMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
Humacyte (HUMA) is a Buy

Is Humacyte a Buy, Sell or Hold?

  • The current Humacyte [HUMA] share price is $4.52. The Score for HUMA is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • HUMA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

YMAB Stock Price Chart

What is Y-mAbs Therapeutics's stock price today?

  • The Y-mAbs Therapeutics share price today is $12.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing selling pressure, which indicates risk of future bearish movement.

HUMA Stock Price Chart

What is Humacyte's stock price today?

  • The Humacyte share price today is $4.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HUMA is experiencing slight selling pressure.

YMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 34.3 Sell
Chaikin Money Flow: -507827 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.03 - 16.29) Sell
Bollinger Bands (100): (9.68 - 16.9) Sell

HUMA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 70.57 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.13 - 4.33) Buy
Bollinger Bands (100): (2.8 - 4) Buy

YMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.88 Sell
20-day SMA: 15.38 Sell
50-day SMA: 15.62 Sell
200-day SMA: 9.42 Buy
8-day EMA: 15.23 Sell
20-day EMA: 15.4 Sell
50-day EMA: 14.97 Sell
200-day EMA: 11.21 Buy

HUMA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.41 Buy
20-day SMA: 3.9 Buy
50-day SMA: 3.52 Buy
200-day SMA: 3.17 Buy
8-day EMA: 4.39 Buy
20-day EMA: 4.04 Buy
50-day EMA: 3.69 Buy
200-day EMA: 3.34 Buy

Y-mAbs Therapeutics Earnings Growth & YMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.27 per share.

Humacyte Earnings Growth & HUMA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.01 per share, an increase this year of $0.11 per share, and an increase next year of $0.16 per share.

Y-mAbs Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Humacyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):